SLC2A1 and neoplasm: After the tumor cells were treated with 1 and 2 nM of BAY‐876, the M2Φ fraction decreased to 15.5% and 9.8%, respectively, suggesting lactate excretion from tumor cells was successfully restricted through GLUT1‐inhibition.